Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Operations

v3.21.2
Consolidated Statements of Operations - USD ($)
12 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Consolidated Statements of Operations    
Revenue $ 11,565 $ 0
Operating expenses:    
Cost of revenues 26,282  
Selling, general and administrative expenses 5,009,323 3,741,020
Research and development expenses 1,353,084 1,611,094
Total costs and expenses 6,388,689 5,352,114
Loss from operations (6,377,124) (5,352,114)
Other income:    
Interest expense (150,531) (18,534)
Gain on forgiveness of loan 178,229  
Decrease to fair value of derivative 108,944 679,271
Total other income 136,642 660,737
Net loss $ (6,240,482) $ (4,691,377)
Loss per share - basic and diluted    
Net loss per common share - basic $ (0.03) $ (0.02)
Net loss per common share - diluted $ (0.03) $ (0.02)
Weighted common shares - basic 220,001,412 188,051,683
Weighted common shares - Diluted 220,001,412 188,051,683